Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and Belgium

Table 1 Coverage period and grace period definitions (in days)

	PP3M	PP1M	Risperidone microspheres
Coverage period	90	30	14
Grace period (base case)^a	90 + 21 = 111	30 + 10 = 40	14 + 5 = 19
Grace period (sensitivity analysis)	120	120	120

^aThe grace period in the base case was set as the coverage period of 1 unit plus 150% of the administration window to avoid a missed dose. The coverage period and administration window was based on the summary of product characteristics (SmPC) by the European Medicines Agency. The administration window of risperidone microspheres was not mentioned in the SmPC and was set as half of that of PP1M

ISSN: 1471-244X